AI Visibility Scorecard
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website
lowher2levels.com · Healthcare
At 1.55/10, ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website is near-invisible in AI search today. Most AI engines will not name it when asked about its category. The weakest signals are Structured Data, E-E-A-T Signals and Backlinks. That is fixable, and the signals below show where to start.
AI engines read this profile 3 times
Claude · Apple Intelligence
Top 50% in Healthcare for AI visibility
7
AI Naming Predictability
iRarely named · 7/100
Healthcare average 11
Top 55% of Healthcare
See what's behind this score →1.55
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →30
Muse Index Score
iAI agent readiness
Agent-ready · 30/100
Healthcare average 18
See what's behind this score →0
About ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website
from our crawl and measurement
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website describes itself simply: "Learn about ENHERTU® (fam-trastuzumab deruxtecan-nxki), including clinical trial results and safety data." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 1.55 out of 10.
Our crawl found structured data on the page (MedicalWebPage). It is missing an llms.txt file, a sitemap and a heading structure that lays out what it offers.
AI crawlers have read this profile 3 times in our tracking, including ClaudeBot (Anthropic) and Applebot (Siri).
- Company ·
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website
- Website ·
- lowher2levels.com
- Industry ·
- Healthcare
- Site status ·
- Live (The website showed an active business site when last checked (Nov 1, 2026).)
- Last scored ·
- Nov 9, 2026
The 6 on-page signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
The 6 off-page signals AI reads
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
-
Not yet measured.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 1.55/10, ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website is near-invisible to AI engines today. That is fixable, and the signals above are where to start.
Why your brand doesn't show up in ChatGPT answers (and how to fix it)
ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website.
Source & Attribution
Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/lowher2levels
Cite this score: Engagemii (2026). "AEO Score for ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website." Retrieved from https://engagemii.com/aeo/brands/lowher2levels
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform